Image

Accuracy of Transcranial Colour Coded Duplex in Comparing With CT Angiography

Accuracy of Transcranial Colour Coded Duplex in Comparing With CT Angiography

Recruiting
All
Phase N/A

Powered by AI

Overview

Investigator will compare accuracy of transcranial colour coded duplex with CT angiography in detecting arterial obstructions in patients presenting or with history of cerebrovascular ischemic strokes

Description

Cerebrovascular stroke is one of the most common causes of death and disability in the World. It accounts for almost 5% of all disability-adjusted life-years and 10% of all deaths worldwide.

Atherosclerosis is one of the major causes of ischemic stroke, it can lead to cerebrovascular stroke through progressive stenosis, occlusion of the extra or intracranial vessels and or arterio-arterial embolization from an atheromatous plaque.

Intracranial stenosis presents with one or recurrent ischemic strokes and transient ischemic attacks.

High-grade stenosis contributes to both the occurrence and magnitude of ischemic injury.

Overall, 50% of patients have either lacunar, subcortical, or cortical infarction.

The remaining patients with intracranial stenosis have multiple lesions involving a combination of cortical, subcortical, and lacunar infarctions.

There are extensive data about carotid atherosclerosis from American, European and Asian population. However, data from Egyptian ethnics are extremely rare.

Ethnic-racial factors are related to the development of extra- and intracranial atherosclerosis.

Intracranial stenosis causes about 10% of strokes in white people, 20-29% of transient ischemic attacks or strokes in black people, and up to 40-50% of strokes in Asian people.

Extracranial atherosclerosis is common among Caucasian stroke patients. For example, in the United States and Western communities, extracranial carotid artery disease was estimated to be responsible for 20-30% of strokes, while less common in Asian and African populations.

Intracranial arterial stenosis is prevalent in the Egyptian stroke population, similar to most non-white populations.

Transcranial Doppler is routinely performed to assess the blood flow in patients with cerebral ischaemia and provides important real-time information about cerebral haemodynamics.

Transcranial doppler can aid in the diagnostic work-up by detecting, localising and grading the severity of intracranial arterial obstruction.

Transcranial Doppler is an established tool for the non-invasive assessment of cerebral blood flow. Since transcranial doppler results vary with the skills and experience of the sonographer, it requires validation against contrast angiography.

Eligibility

Inclusion Criteria:

  • patients who have acute ischemic strokes or transient ischemic attacks .

Exclusion Criteria:

  1. Patients with history of cardiac arrhythmia or discovered recently or known rheumatic heart disease.
  2. Patients with history of autoimmune diseases.
  3. Patients with space occupying lesion or hemorrhage in Ct brain.
  4. Pregnant female.
  5. Patients who refuse to participate in the study.
  6. Patients who have history of allergy or developed acute kidney injury during previous dye injection.
  7. Patients who have chronic kidney disease.
  8. Premorbid neurological disorder (myopathy, multiple sclerosis) on neurological examination or previous investigations.
  9. Inability to achieve safe vascular access.
  10. Patients with insufficient temporal acoustic window.

Study details
    Ischemic Stroke
    Acute

NCT06920303

Sohag University

16 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.